Cargando…
2447. Ertapenem and Faropenem for the Treatment of Drug-Resistant Tuberculosis
BACKGROUND: Carbapenems are a class of β-lactam antibiotics which include imipenem, meropenem and ertapenem. More recently, a new oral carbapenem (faropenem) have been marketed in a limited number of countries (in particular, India and Japan). Emerging evidence demonstrates that they target the myco...
Autores principales: | Satta, Giovanni, Gonzalo, Ximena, Canseco, Julio Ortiz, Wey, Emmanuel, Drobniewski, Francis, McHugh, Timothy D |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6254036/ http://dx.doi.org/10.1093/ofid/ofy210.2100 |
Ejemplares similares
-
Ertapenem and Faropenem against Mycobacterium tuberculosis: in vitro testing and comparison by macro and microdilution
por: Gonzalo, Ximena, et al.
Publicado: (2020) -
798. The Role of Whole-Genome Sequencing in Characterizing the Mechanism of Action of Anti-Tuberculosis Compounds: Demonstrated With Para-Amino Salicylic Acid and Its Analogue
por: Satta, Giovanni, et al.
Publicado: (2018) -
Generalized Bullous Drug Eruption to Faropenem - Hitherto Unreported
por: Gangopadhyay, Anusree, et al.
Publicado: (2017) -
Are the Newer Carbapenems of Any Value against Tuberculosis
por: Gonzalo, Ximena, et al.
Publicado: (2022) -
Optimal Clinical Doses of Faropenem, Linezolid, and Moxifloxacin in Children With Disseminated Tuberculosis: Goldilocks
por: Srivastava, Shashikant, et al.
Publicado: (2016)